Search results for: Adrian Towse

OHE’s Towse on Challenges in Valuing Genomic Medicines

23 May 2013

…Adrian Towse from Office of Health Economics Related OHE publications and materials include the following. Garau, M., Towse, A., Garrison, L., Housman, L. and Ossa, D. (2013) Can and should…

OHE in the Spotlight: Summer 2011

22 September 2011

…In June, Adrian Towse presented his recent research on optimal pricing of pharmaceuticals across and within countries at the University of York’s Centre for Health Economics and at the University…

OHE at ISPOR Philadelphia: Presentations and Posters

4 June 2015

…large prevalence diseases? Lessons from hepatitis C – Adrian Towse’s slides Early access to medicines: What is in it for payers? – Adrian Towse’s slides An Analysis of NICE ‘Recommended…

OHE at ISPOR May 2016: Meet the Team

19 May 2016

…the following sessions: Short course: Risk Sharing / Performance-Based Arrangements for Drugs and Other Medical Products OHE Authors: Adrian Towse Time and date: Saturday 21st May, 8:00am Summary: There is…

OHE at ISPOR Boston 2017: Presentations and Posters

4 July 2017

…Office of Health Economics   Adrian Towse also moderated an issues panel on: Perspectives on the relationship between cost effectiveness and affordability. Adrian introduced the topic, highlighting relevant papers and…

Foundation

…of agency and insurance are key concepts in the paper, called ‘Uncertainty and the Welfare Economics of Medical Care’, explains Professor Adrian Towse, Director Emeritus of the Office of Health Economics…

Towse at ISPOR: Macro HTA and Managed Entry Agreements

7 October 2014

Adrian Towse, currently President of ISPOR, contributed to two session at the recent ISPOR Asia-Pacific conference. Using HTA to maximise health system performance: Health technology assessment (HTA) is familiar as…

OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad

19 June 2015

…Adrian Towse then presented The NDDP project – Implications for Drug Development.   Towse nddp implications for drug development v1 from Office of Health Economics   Sean Tunis facilitated a…

Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing

13 October 2011

…the third ISPOR Latin American Conference. With Lou Garrison, University of Washington, Adrian Towse presented the findings of a study by the Office of Health Economics and Veritech. Adrian presented…